Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zachary Laksman, MD"'
Autor:
Sina Safabakhsh, BSc, Abdullah Al-Shaheen, MD, Elizabeth Swiggum, MD, Lisa Mielniczuk, MD, Maxime Tremblay-Gravel, MD, Zachary Laksman, MD, MSc
Publikováno v:
CJC Open, Vol 4, Iss 11, Pp 959-969 (2022)
Heart failure with preserved ejection fraction (HFpEF) is an increasingly recognized disorder. Many clinical trials have failed to demonstrate benefit in patients with HFpEF but have recognized alarming rates of sudden cardiac death (SCD). Genetic te
Externí odkaz:
https://doaj.org/article/06002ad6316242d8b5b8e7d69b6a0015
Autor:
Sina Safabakhsh, BSc, Darson Du, MD, Janet Liew, BSc, Jeremy Parker, PhD, Cheryl McIlroy, BSN, Elina Khasanova, MD, Praveen Indraratna, MD, Philipp Blanke, MD, Jonathon Leipsic, MD, Jason G. Andrade, MD, Matthew T. Bennett, MD, Nathaniel M. Hawkins, MBChB, MD, Shantabanu Chakrabarti, MD, John Yeung, MD, Marc W. Deyell, MD, Andrew D. Krahn, MD, FHRS, Robert Moss, MD, Kevin Ong, MD, Zachary Laksman, MD, MSc
Publikováno v:
CJC Open, Vol 4, Iss 3, Pp 305-314 (2022)
Background: Sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) currently relies on arrhythmic burden quantification by 24 or 48-hour Holter monitoring. Whether this approach adequately captures arrhythmic burden, comp
Externí odkaz:
https://doaj.org/article/c1170a9da7514c05b8db6278b2e4971f
Autor:
Drake A. Comber, MSc, Ashley DeGraaf, MSc, Derek Human, BM BCh, MA, Amanda Barlow, MD, Praveen Indraratna, MBBS, Gnalini Sathananthan, MBBS, Zachary Laksman, MD, MSc
Publikováno v:
CJC Open, Vol 3, Iss 11, Pp 1396-1399 (2021)
Patients with heritable aortic disease (HAD) have an increased risk of ventricular arrhythmias and sudden cardiac death. Although mitral valve prolapse is common in HAD, mitral annulus disjunction (MAD) has only recently been described in these patie
Externí odkaz:
https://doaj.org/article/7ef99fff747d48e2ac4b84eb48be33b7
Autor:
Nelson Lu, MD, Jenny MacGillivray, BScPharm, Jason G. Andrade, MD, FHRS, Andrew D. Krahn, MD, FHRS, Nathaniel M. Hawkins, MD, Zachary Laksman, MD, Marc W. Deyell, MD, MSc, FHRS, Shanta Chakrabarti, MD, FHRS, John A. Yeung-Lai-Wah, MD, Matthew T. Bennett, MD, FHRS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 1, Pp 46-52 (2021)
Background: Rate control medications are foundational in the management of persistent atrial fibrillation (AF). There are no guidelines for adjusting these medications prior to elective direct-current cardioversion (DCCV). Objective: To derive and va
Externí odkaz:
https://doaj.org/article/6f8ef55081704c42b4c68b2662c121a8
Publikováno v:
CJC Open, Vol 3, Iss 8, Pp 1079-1081 (2021)
A young man with baseline early repolarization was initiated on flecainide and diltiazem for symptomatic atrial arrhythmias. A treadmill stress test induced a type 1 Brugada electrocardiogram pattern at higher heart rates. Flecainide was discontinued
Externí odkaz:
https://doaj.org/article/bbc36166c90a413d96e386339a0a67d2